Lung Cancer Metastatic Clinical Trials

46 clinical trials for Lung Cancer Metastatic across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Primary Tumor Resection for M1a Stage Lung Cancer — RECRUITING
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain — RECRUITING · PHASE2
• Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer — RECRUITING · PHASE1
• A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs — RECRUITING · PHASE1
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer — RECRUITING · NA
• TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer — RECRUITING · PHASE1
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy — RECRUITING
• Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer — COMPLETED · PHASE1
• Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO — ACTIVE_NOT_RECRUITING · PHASE3
• BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) — NOT_YET_RECRUITING · PHASE3
• A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC — TERMINATED · PHASE2
• Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy — COMPLETED · NA
• Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC — ACTIVE_NOT_RECRUITING · PHASE2
• Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers — TERMINATED · PHASE1
• Pembro+Chemo in Brain Mets — TERMINATED · PHASE2
• Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer — ACTIVE_NOT_RECRUITING · NA
• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) — COMPLETED · PHASE2
• Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer — WITHDRAWN · PHASE2
• SPSIPB vs SAPB for Thoracoscopic Surgery — COMPLETED · NA
• A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib. — COMPLETED · PHASE1
• DBT for Metastatic Lung Cancer — COMPLETED · NA
• Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System — WITHDRAWN
• Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC) — COMPLETED
• ANET Electrosurgery Applicator Pilot Evaluation Study — TERMINATED · NA
• A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib — COMPLETED · PHASE1
• Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer — OTHER · NA
• The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer — OTHER
• Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer — COMPLETED · PHASE2
• Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC — TERMINATED · PHASE2
• Needlescopic-assisted Uniportal vs Uniportal VATS — COMPLETED · NA
• Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment — OTHER
• Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC — OTHER · PHASE1
• Safety of PDT-Photofrin® Prior to Lung Surgery — COMPLETED · PHASE1
• Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors — TERMINATED · NA
• Early Palliative Care in Metastatic Lung Cancer in Northern France — TERMINATED · NA
• Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer — COMPLETED
• Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC — OTHER · PHASE2
• PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities — OTHER · PHASE2
• Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation — OTHER · PHASE2
• Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer — OTHER · PHASE1
• Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation — OTHER · PHASE2
• Clinical Validation of the M5L Lung CAD — COMPLETED
• SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy — OTHER · PHASE2

Refine this search